Autobrains
13.3.2024 14:57:29 CET | ACCESS Newswire | Press release
Autobrains, an automotive AI powerhouse, is unveiling its new groundbreaking AI technology, Liquid AI, which effectively tackles the three major challenges in today's automotive AI landscape - covering edge cases, achieving a viable cost point, and bridging the gap between perception and decision.
TEL AVIV, ISRAEL and MUNICH, GERMANY / ACCESSWIRE / March 13, 2024 / Autobrains, a leader in automotive AI headquartered in Tel Aviv, introduces its latest breakthrough: Liquid AI. Liquid AI represents a paradigm shift in autonomous driving and Advanced Driver Assistance Systems (ADAS), addressing challenges that even the best automotive companies struggle to overcome. It combines Autobrains' signature-based self-learning approach with a modular and adaptive architecture of specialized, scenario-based end-to-end skills. "While current technologies perform well in handling average conventional driving tasks, they fall short when faced with unexpected real-world driving scenarios that demand greater precision. By using or implementing our Liquid AI, automotive companies can close their AI gaps," adds Autobrains' Founder and CEO, Igal Raichelgauz.
To view this piece of content from cdn.nwe.io, please give your consent at the top of this page.The Challenges Faced by Conventional AI Systems:
- Edge Cases: The infinite variety of unexpected driving scenarios presents conventional AIs with practically unsolvable tasks. Today's manually trained black-box systems cannot cover edge cases. Attempts to address this by feeding the systems more labeled images result in a loss of trackability and controllability.
- Cost: Addressing real-world driving problems by expanding existing systems with more data, labeling, layers, and computational resources leads to escalating costs and power consumption, resulting in diminishing returns. Achieving a substantial improvement in system accuracy by a factor of 10 requires 10,000 times more computational resources.
- Perception-Decision Disconnect: The missing interplay between perception and decision functions hinders effective and precise decision-making. For the AI to make optimal driving choices, it requires specific information. However, when details are missing or overly complex, precision is compromised, leading to incorrect reactions.
Liquid AI - Human Brain-Inspired:
Autobrains draws inspiration from the human brain, which consists of specialized areas akin to task-specific narrow end-to-end AIs. Just as our brain adapts its architecture based on context - such as light/weather conditions, surroundings, and relevant road users - Liquid AI follows the same approach. Here's how it works:
- Network of Specialized Narrow AIs: Liquid AI comprises hundreds of thousands of specialized narrow AIs, each designed for specific tasks, making reactions very precise and tailored to the relevant driving scenario. This specialized AI approach enables scalability, ranging from a few tens to hundreds of AIs for ADAS systems, scaling up to thousands for higher levels of automated driving, all the way to hundreds of thousands of AIs for full self-driving.
- Adaptive Architecture: Unlike fixed systems, Liquid AI's architecture adapts dynamically to the driving context, activating only relevant modules as necessary. This significantly reduces power consumption and compute requirements, not only resulting in cost savings for the System on Chip (SoC) hardware.
- Efficiency and Precision: By mimicking the brain's flexibility, Liquid AI achieves superior performance, cost-effectiveness, and safety.
The Future of Automotive Intelligence:
Autobrains' Liquid AI bridges the gap between conventional AI limitations and the promise of truly intelligent autonomous systems. By mimicking the human brain's flexibility, Liquid AI achieves superior performance, cost-effectiveness, and more explainability and controllability.
About Autobrains
Autobrains is a leading AI company in the automotive industry. Autobrains invented and developed a paradigm-shifting AI technology: Liquid AI - backed by 250+ patents addressing autonomous driving challenges. Implementing this unique AI technology for ADAS applications disrupts the market with its unprecedented perception capabilities, low compute requirements, and agnosicity to sensors and SoCs. The company is backed by strategic investors including Temasek, Knorr-Bremse AG, BMW i Ventures, Toyota Ventures, VinFast, Continental AG, and Autel.
Learn more: https://autobrains.ai.
Contact: sales@autobrains.ai
Contact Information
Sophia Eichler
Director of Marketing
media@autobrains.ai
+49 015167066494
SOURCE: Autobrains
To view this piece of content from stats.nwe.io, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Caldwell Strengthens Life Sciences and Healthcare Practice with Addition of Dr. Christoph Themel as Partner3.2.2026 11:30:00 CET | Press release
TORONTO, ON AND LONDON, UK / ACCESS Newswire / February 3, 2026 / Retained executive search firm Caldwell (TSX:CWL)(OTCQX:CWLPF) today announced the addition of Dr. Christoph Themel as a Partner in the firm's Life Sciences and Healthcare Practice. Based in London, Dr. Themel advises boards, investors, and senior leadership teams on executive and non-executive appointments, leadership assessments, and succession planning across the pharmaceutical, biotechnology, and animal health sectors. Dr. Christoph Themel joins Caldwell as partner in the firm's Life Sciences and Healthcare Practice With more than 20 years of experience in executive search and leadership advisory, Dr. Themel is a trusted advisor to big and mid-sized pharmaceutical companies, family-owned enterprises, private equity firms, and portfolio company leadership teams across Europe, the United States, and Asia Pacific. He is particularly known for his ability to partner closely with shareholders and management teams on C-sui
AI Rises on the Finance Leadership Agenda as Cost Control Dominates 2026, New Survey Reveals3.2.2026 10:00:00 CET | Press release
MANCHESTER, UK / ACCESS Newswire / February 3, 2026 / AccessPay, the leading bank integration provider, today announced the release of its Finance Trends 2026 report, presenting the findings of its annual survey of finance leaders. In this fourth year of the report, AccessPay reveals marked sectoral differences between finance teams in financial services firms and those in corporates with regards to their priorities and attitudes to technology adoption. Key findings from the report include: 1. Finance leaders are prioritising finance efficiency and cost control Finance teams across all sectors are placing renewed emphasis on efficiency and cost control in 2026. 47% of general corporates cited this as a priority, a goal shared by 46% of financial services firms. Although cost control is a perennial concern in financial management, sluggish economic growth, rising costs, and geopolitical turmoil have brought it to the fore. Finance leaders are being pushed to do more with less, which als
Formerra and Evonik Expand Distribution Partnership for Healthcare Grades2.2.2026 15:00:00 CET | Press release
Agreement Expands Access to Evonik's CARE Brand Medical Grades in the U.S. and Canada ROMEOVILLE, ILLINOIS / ACCESS Newswire / February 2, 2026 / Formerra, a leader in performance materials distribution, today announced an expanded distribution agreement that brings Evonik's CARE brand healthcare grades into Formerra's medical portfolio. Covering the United States and Canada, the agreement creates new access points for high-performance polyamides used in essential healthcare applications. This expansion kicks off at MD&M West 2026 this week, and underscores both companies' commitment to supporting the healthcare market with high-performance materials, responsive service, and continuity of supply. It also builds on the companies' two-year partnership, which introduced Evonik's VESTAMID® and TROGAMID® families to Formerra's engineered materials lineup. With this expansion, Formerra will support Evonik healthcare grades designed for fluid handling, drug delivery, diagnostic systems, surgi
Hans Vestberg, Former Verizon Chairman and CEO, Joins Digipower X As Senior Advisor2.2.2026 13:30:00 CET | Press release
This news release constitutes a "designated news release" for the purposes of the Company's amended and restated prospectus supplement dated November 18, 2025, to its short form base shelf prospectus dated May 15, 2025. MIAMI, FL / ACCESS Newswire / February 2, 2026 / Digi Power X Inc. ("Digipower X" or the "Company") (Nasdaq:DGXX)(TSXV:DGX), a vertically integrated AI infrastructure company focused on the deployment of Tier-3 modular data centers powered by owned and controlled energy assets, today announced that Hans Vestberg, former Chairman and Chief Executive Officer of Verizon Communications, has joined the Company as a senior advisor serving on its Advisory Board to support the Company's expansion strategy. Mr. Vestberg brings more than three decades of global leadership in mission-critical infrastructure, telecommunications networks, and large-scale capital deployment. He is widely recognized for leading Verizon's first commercial 5G deployment in 2018 and for advancing nationw
Formerra to Supply Foster Medical Compounds in Europe29.1.2026 15:00:00 CET | Press release
Expanded agreement infuses Formerra's European healthcare polymer portfolio with life-saving Foster® compounds. PUTNAM, CT AND ROMEOVILLE, IL / ACCESS Newswire / January 29, 2026 / Formerra and GEON® Performance Solutions today announced an agreement that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in Europe. This adds to Formerra's current distribution of these materials in North and South America, enabling Formerra to now support customers who need the same product in all regions. Following GEON's January 2025 acquisition of Foster, the agreement builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials. "Bringing Foster's medical-grade portfolio to Europe strengthens our ability to support healthcare manufacturers across the region with specialized compounds and the local expertise they need to navigate complex regulatory environments," said Kelly Wessner, Vice President, Key
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom